Explore The New Health StartUps for Haemophilia - Net4Hemo and Current Advancements for Haemophilia patients

New advancements in haemophilia must be encouraged on World Haemophilia Day. People should be aware of the benefits of new health startups for haemophilia patients for effective management of this disorder.

Haemophilia is a genetic disorder characterized by uncontrollable or severe bleeding on joints, muscles or other soft tissues. Patients affected with haemophilia are prone to easy bruising and may bleed easily. Current methods of treatments are being evaluated and are under research for better management and patient care. Administration of the clotting factor is the only treatment available for haemophilia patients. Gene therapy for haemophilia is a curative treatment under investigation and can be a lifesaver for many patients. 

Effective management of Haemophilia is a must 

Poor understanding of the pathophysiological mechanism involved in haemophilia is a major obstacle and hurdle in assessing effective haemophilia treatment and disease management. Haemophilia is a life-threatening disorder and can lead to repeated bleeding events which can affect the patient and his health. Various approaches have been put forward to help out haemophilia patients like coagulation factor replacement therapy to effective control haemophilia treatment and control. Let’s not forget that this is an inherited disorder and needs special attention in symptomatic patients to avoid bleeding. 

The app Net4Hemo for haemophilia patients is truly turning a boom nationwide

Net4Hemo is a mobile application which is providing information and measures to haemophilia patients to stay safe and healthy by being prepared with their treatment plans. The application is developed by Periwinkle Technologies Pvt Ltd. It is a Pune based company co-founded by Veena Moktali and Koustubh Naik. Net4Hemo is a finalist for Mbillionth Award organised by Digital Empowerment Foundation 2017 in the “Early Stage Category”

The operation of Net4Hemo for haemophilia patients

Net4Hemo provides remote consultation from doctors to haemophilia patients who need special care and attention. It is a responsive digital healthcare platform that not only helps in treating faster but also helps to reduce the travel time, wait time for the patient with the implementation of effective management strategies for haemophilia patients. Net4Hemo is a medical online platform with a whats app-like interface for registering birth defects and bleeding disorders to provide support to the patients affected by this bleeding disorder. The app allows patients to keep track of bleeding incidences to their doctors allocated or chosen by them so that accurate information can be kept to analyse their detailed case consultation and regular follow-ups with doctors. 

This way, their doctor can administer the correct line of treatment and work up effective strategies for perfect management of haemophilia. This system also allows prompt messaging and video consultation through your android or smartphones. As of now, they have 10 doctors and 800 patients subscribed to the app which has proved quite beneficial to the patient. 

Current advancements in management and treatment of haemophilia. 

There are many current advancements that are coming up for the management of haemophilia which concentrates on altered pharmacokinetics and dynamics of the clotting factor for better treatment and management of haemophilia. New novel techniques are coming into light with the current gene therapy which has made news for the treatment of haemophilia and for those affected with a severe bleeding disorder. Gene therapy for haemophilia is still in clinical trials and there is a need for well designed clinical trials to assess the long term feasibility and success rate of the management of haemophilia.

Tags : #startups #worldhaemophiliaday #Net4Hemo #haemophilia #healthstartups

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024